UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Thromboxane Modulating Agents. 3. 1H-Imidazol-1-ylalkyl- and 3-Pyridinylalkyl-Substituted 3-[2-[(Arylsulfonyl)amino]ethyl]benzenepropanoic Acid Derivatives as Dual Thromboxane Synthase Inhibitor/Thromboxane Receptor Antagonists

Journal of medicinal chemistry, 1997-10, Vol.40 (21), p.3442-3452

1997

Volltextzugriff (PDF)

Thromboxane modulating agents. 4. Design and synthesis of 3-(2-[{(4-chlorophenyl)sulfonyl}amino]ethyl)benzenepropanoic acid derivatives as potent thromboxane receptor antagonists

Bioorganic & medicinal chemistry letters, 1998-08, Vol.8 (16), p.2061-2066

1998

Volltextzugriff (PDF)

Absorption, distribution, metabolism, and excretion considerations in selection of orally active indole-containing endothelin antagonist

Drug metabolism and disposition, 2001-11, Vol.29 (11), p.1424

2001

Volltextzugriff (PDF)

A mild and selective C-3 reductive alkylation of indoles

Tetrahedron letters, 1993-02, Vol.34 (9), p.1529-1532

1993

Volltextzugriff (PDF)

The design and synthesis of a novel series of indole derived selective ETA antagonists

Bioorganic & medicinal chemistry letters, 2002-01, Vol.12 (2), p.125-128

2002

Volltextzugriff (PDF)

Thromboxane modulating agents. 1. Design of 1-[(arylsulfonyl)amino] alkylindole derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists

Bioorganic & medicinal chemistry letters, 1995-12, Vol.5 (24), p.3017-3022

1995

Volltextzugriff (PDF)

Thromboxane modulating agents. 2. Thromboxane receptor antagonists derived from the thromboxane synthase inhibitor dazmegrel

Bioorganic & medicinal chemistry letters, 1996-07, Vol.6 (14), p.1691-1696

1996

Volltextzugriff (PDF)

ChemInform Abstract: Thromboxane Modulating Agents. Part 4. Design and Synthesis of 3-(2-[{(4-Chlorophenyl)sulfonyl}amino]ethyl)benzenepropanoic Acid Derivatives as Potent Thromboxane Receptor Antagonists

ChemInform, 1999-01, Vol.30 (1), p.no-no

1999

Volltextzugriff (PDF)

ChemInform Abstract: A Mild and Selective C-3 Reductive Alkylation of Indoles

ChemInform, 1993-07, Vol.24 (28), p.no-no

1993

Volltextzugriff (PDF)

Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial

Thorax, 2022-05, Vol.77 (5), p.461-469

2022

Volltextzugriff (PDF)

In vitro and in vivo characterization of PF‐04418948, a novel, potent and selective prostaglandin EP 2 receptor antagonist

British journal of pharmacology, 2011-12, Vol.164 (7), p.1847-1856

2011

Volltextzugriff (PDF)

Topical ‘dual-soft’ glucocorticoid receptor agonist for dermatology

Bioorganic & medicinal chemistry letters, 2020-09, Vol.30 (17), p.127402-127402, Article 127402

2020

Volltextzugriff (PDF)

Characterization of Recombinant Respiratory Syncytial Viruses with the Region Responsible for Type 2 T-Cell Responses and Pulmonary Eosinophilia Deleted from the Attachment (G) Protein

Journal of Virology, 2004-08, Vol.78 (16), p.8446-8454

2004

Volltextzugriff (PDF)

In vitro and in vivo characterization of PF‐04418948, a novel, potent and selective prostaglandin EP2 receptor antagonist

British journal of pharmacology, 2011-12, Vol.164 (7), p.1847-1856

2011

Volltextzugriff (PDF)

Recombinant Respiratory Syncytial Viruses Lacking the C-Terminal Third of the Attachment (G) Protein Are Immunogenic and Attenuated In Vivo and In Vitro

Journal of Virology, 2004-06, Vol.78 (11), p.5773-5783

2004

Volltextzugriff (PDF)

Task Force 2: The physician in the office (adult medicine)

The American journal of cardiology, 1981-03, Vol.47 (3), p.747-751

1981

Volltextzugriff (PDF)

Abstracts

American journal of digestive diseases, 1939-03, Vol.6 (3), p.212-230

1939

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(17)

Sprache

Englisch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Thromboxane Modulating Agents. 3. 1H-Imidazol-1-ylalkyl- and 3-Pyridinylalkyl-Substituted 3-[2-[(Arylsulfonyl)amino]ethyl]benzenepropanoic Acid Derivatives as Dual Thromboxane Synthase Inhibitor/Thromboxane Receptor Antagonists

Thromboxane modulating agents. 4. Design and synthesis of 3-(2-[{(4-chlorophenyl)sulfonyl}amino]ethyl)benzenepropanoic acid derivatives as potent thromboxane receptor antagonists

Absorption, distribution, metabolism, and excretion considerations in selection of orally active indole-containing endothelin antagonist

A mild and selective C-3 reductive alkylation of indoles

The design and synthesis of a novel series of indole derived selective ETA antagonists

Thromboxane modulating agents. 1. Design of 1-[(arylsulfonyl)amino] alkylindole derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists

Thromboxane modulating agents. 2. Thromboxane receptor antagonists derived from the thromboxane synthase inhibitor dazmegrel

ChemInform Abstract: Thromboxane Modulating Agents. Part 4. Design and Synthesis of 3-(2-[{(4-Chlorophenyl)sulfonyl}amino]ethyl)benzenepropanoic Acid Derivatives as Potent Thromboxane Receptor Antagonists

ChemInform Abstract: A Mild and Selective C-3 Reductive Alkylation of Indoles

Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial

In vitro and in vivo characterization of PF‐04418948, a novel, potent and selective prostaglandin EP 2 receptor antagonist

Topical ‘dual-soft’ glucocorticoid receptor agonist for dermatology

Characterization of Recombinant Respiratory Syncytial Viruses with the Region Responsible for Type 2 T-Cell Responses and Pulmonary Eosinophilia Deleted from the Attachment (G) Protein

In vitro and in vivo characterization of PF‐04418948, a novel, potent and selective prostaglandin EP2 receptor antagonist

Recombinant Respiratory Syncytial Viruses Lacking the C-Terminal Third of the Attachment (G) Protein Are Immunogenic and Attenuated In Vivo and In Vitro

Task Force 2: The physician in the office (adult medicine)

Abstracts

Aktive Filter

Suchergebnisse filtern